Risk factors for recurrence following radical cystectomy for pathologic node negative bladder cancer

Journal of Surgical Oncology

Volumn 102, Issue 4, 2010, Pages 334-337

  Hugen, Cory M ^a   Polcari, Anthony J ^a   Fitzgerald, Mary P ^a   Dauw, Casey ^a   Flanigan, Robert C ^a   Quek, Marcus L ^a  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

Bladder malignancy; Lymphadenectomy; Recurrence

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER INVASION; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CARCINOMA IN SITU; CYSTECTOMY; FEMALE; HUMAN; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR;

AGED; CYSTECTOMY; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RETROSPECTIVE STUDIES; RISK FACTORS; URINARY BLADDER NEOPLASMS;

EID: 77956567007     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21642     Document Type: Article

References (20)

1. Stein JP, Lieskovsky G, Cote R, et al.: Radical cystectomy in the treatment of invasive bladder cancer: Long-term results in 1,054 patients. J Clin Oncol 2001;19:666-675.
2. Herr HW: Extent of surgery and pathology evaluation has an impact on bladder cancer outcomes after radical cystectomy. Urology 2003;61:105-108.
3. Quek ML, Sanderson KM, Daneshmand S, et al.: The importance of an extended lymphadenectomy in the management of high-grade invasive bladder cancer. Expert Rev Anticancer Ther 2004;4:1007-1016.
4. Herr HW, Bochner BH, Dalbagni G, et al.: Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer. J Urol 2002;67:1295-1298.
5. Leissner J, Hohenfellner R, Thuroff JW, et al.: Lymphadenectomy in patients with transitional cell carcinoma of the urinary bladder; significance for staging and prognosis. BJU Int 2000;85:817-823.
6. Lerner SP, Skinner DG, Lieskovsky G, et al.: The rationale for en bloc pelvic lymph node dissection for bladder cancer patients with nodal metastases: Long-term results. J Urol 1993;149:758-764.
7. Stein JP, Cai J, Groshen S, et al.: Risk factors for patients with pelvic lymph node metastases following radical cystectomy with en bloc pelvic lymphadenectomy: Concept of lymph node density. J Urol 2003;170:35-41.
8. Wright JL, Lin DW, Porter MP: The association between extent of lymphadenectomy and survival among patients with lymph node metastases undergoing radical cystectomy. Cancer 2008;112:2401-2408.
9. Honma I, Masumori N, Sato E, et al.: Removal of more lymph nodes may provide better outcome, as well as more accurate pathologic findings, in patients with bladder cancer - Analysis of role of pelvic lymph node dissection. Urology 2006;68:543-548.
10. Poulsen AL, Horn T, Steven K: Radical cystectomy: Extending the limits of pelvic lymph node dissection improves survival for patients with bladder cancer confined to the bladder wall. J Urol 1998;160:2015-2020.
11. Shariat SF, Karakiewicz PI, Palapattu GS, et al.: Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: A contemporary series from the Bladder Cancer Research Consortium. J Urol 2006;176:2414-2422.
12. Quek ML, Stein JP, Nichols PW, et al.: Prognostic significance of lymphovascular invasion of bladder cancer treated with radical cystectomy. J Urol 2005;174:103-106.
13. Leissner J, Koeppen C, Wolf HK: Prognostic significance of vascular and perineural invasion in urothelial bladder cancer treated with radical cystectomy. J Urol 2003;169:955-960.
14. Herr H, Lee C, Chang S, et al.: Standardization of radical cystectomy and pelvic lymph node dissection for bladder cancer: A collaborative group report. J Urol 2004;171:1823-1828.
15. Dhar NB, Campbell SC, Zippe CD, et al.: Outcomes in patients with urothelial carcinoma of the bladder with limited pelvic lymph node dissection. BJU Int 2006;98:1172-1175.
16. Konety BR, Joslyn SA, O'Donnell MA: Extent of pelvic lymphadenectomy and its impact on outcome in patients diagnosed with bladder cancer: Analysis of data from the surveillance, epidemiology and end results program database. J Urol 2003;169:946-950.
17. Leissner J, Ghoneim MA, Abol-Enein H, et al.: Extended radical lymphadenectomy in patients with urothelial bladder cancer: Results of a prospective multicenter study. J Urol 2004;171:139-144.
18. Bochner BH, Herr HW, Reuter VE: Impact of separate versus en bloc pelvic lymph node dissection on the number of lymph nodes retrieved in cystectomy specimens. J Urol 2001;166:2295-2296.
19. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines™) Bladder Cancer (Version 2.2010). © 2010. National Comprehensive Cancer Network, Inc. Available at: NCCN.org. Accessed April 30, 2010.
20. Advanced Bladder Cancer (ABC) Meta-analysis Collaboration. Adjuvant chemotherapy in invasive bladder cancer: A systematic review and meta-analysis of individual patient data Advanced Bladder Cancer (ABC) Meta-analysis Collaboration. Eur Urol 2005;48:189-199.